Literature DB >> 30128491

Detection of Complement Activators in Immune Attack Eyes After iPS-Derived Retinal Pigment Epithelial Cell Transplantation.

Sunao Sugita1, Kenichi Makabe1, Shota Fujii1,2, Masayo Takahashi1.   

Abstract

Purpose: To determine whether human induced pluripotent stem (iPS) cell-derived retinal pigment epithelial (RPE) cells (iPS-RPE) can express complement factors.
Methods: To confirm expression of complement factors in human iPS-RPE cells, we performed flow cytometry, immunohistochemistry, ELISA, and quantitative RT-PCR for the following: C3, C5, CFB (Factor B), C5b-9 (membrane attack complex [MAC]), CFH (Factor H), CFI (Factor I), CD46, CD55, CD59, clusterin, and vitronectin. We also prepared iPS-RPE cells in the presence of recombinant IFN-γ, recombinant TNF-α, lipopolysaccharide, supernatants of naïve T cells, and T helper 1 (Th1) cells. For the transplantation, after preparation of iPS-RPE cells from cynomolgus monkeys, the iPS-RPE cells (allografts) were transplanted into the subretinal space in monkeys. After surgery, monkeys were euthanized for IHC evaluation of the retinal section and determination of complement factors (C3, C5, CFB, MAC, and C1q), cytokines, and immunoglobulin G (IgG).
Results: Human iPS-RPE cells expressed complement activators and inhibitors. iPS-RPE cells highly expressed complement factors during inflammatory conditions, especially IFN-γ exposure including Th1 cell supernatants. In immune attack eyes after allogeneic iPS-RPE cell transplantation, complement activators such as C3, CFB, C5, and MAC were detected around the host RPE layer, grafted RPE cells, inflammatory retinal lesions, and transplanted subretinal space. In addition, we observed a large number of C1q and IgG double positive and IFN-γ positive inflammatory cells in the retinal sections. Conclusions: iPS-derived RPE cells greatly expressed complement factors. Thus, RPE cells might be activated and produce complement factors after exposure to infiltrating inflammatory cells in the eye.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30128491     DOI: 10.1167/iovs.18-24769

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

Review 1.  Cell culture models to study retinal pigment epithelium-related pathogenesis in age-related macular degeneration.

Authors:  Kapil Bharti; Anneke I den Hollander; Aparna Lakkaraju; Debasish Sinha; David S Williams; Silvia C Finnemann; Catherine Bowes-Rickman; Goldis Malek; Patricia A D'Amore
Journal:  Exp Eye Res       Date:  2022-07-11       Impact factor: 3.770

2.  Transplantation of GMP-grade human iPSC-derived retinal pigment epithelial cells in rodent model: the first pre-clinical study for safety and efficacy in China.

Authors:  Hang Zhang; Bingnan Su; Luyan Jiao; Ze-Hua Xu; Chang-Jun Zhang; Jinfu Nie; Mei-Ling Gao; Ying V Zhang; Zi-Bing Jin
Journal:  Ann Transl Med       Date:  2021-02

3.  Complement Factor H-Related 3 Enhanced Inflammation and Complement Activation in Human RPE Cells.

Authors:  Nicole Schäfer; Anas Rasras; Delia M Ormenisan; Sabine Amslinger; Volker Enzmann; Herbert Jägle; Diana Pauly
Journal:  Front Immunol       Date:  2021-11-08       Impact factor: 7.561

4.  Retinal Pigment Epithelial Cells Derived from Induced Pluripotent Stem (iPS) Cells Suppress or Activate T Cells via Costimulatory Signals.

Authors:  Sunao Sugita; Yoko Futatsugi; Masaaki Ishida; Ayaka Edo; Masayo Takahashi
Journal:  Int J Mol Sci       Date:  2020-09-05       Impact factor: 5.923

Review 5.  Immunological considerations and challenges for regenerative cellular therapies.

Authors:  Sandra Petrus-Reurer; Marco Romano; Sarah Howlett; Joanne Louise Jones; Giovanna Lombardi; Kourosh Saeb-Parsy
Journal:  Commun Biol       Date:  2021-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.